Also reliably detects all virus mutations that have occurred.

Special approval of the BfArM No. 5640-S-096/21.

The SARS-CoV-2 Antigen Rapid Test is an immunochromatographic in vitro test for the direct and qualitative detection of viral SARS-CoV-2 antigens by an anterior nasal swab.

• Approved for lay and home use.
• High accuracy (98.33 %), specificity (99.33 %) and sensitivity (97.33 %).
• Identification of acute infection.
• BFARM listed (special approval no. 5640-S-096/21.
• Results in 15 min.; result easy to read.
• Storage at room temperature.
• Sample material: anterio nasal (anterior nasal region).

Items supplied:
Tests, test cassettes, sterile swab, test tubes incl. bufferer solution and integrated dropper.